170 related articles for article (PubMed ID: 18398476)
1. Sequence effect of self-assembling peptides on the complexation and in vitro delivery of the hydrophobic anticancer drug ellipticine.
Fung SY; Yang H; Chen P
PLoS One; 2008 Apr; 3(4):e1956. PubMed ID: 18398476
[TBL] [Abstract][Full Text] [Related]
2. Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo.
Wu Y; Sadatmousavi P; Wang R; Lu S; Yuan YF; Chen P
Int J Nanomedicine; 2012; 7():3221-33. PubMed ID: 22802684
[TBL] [Abstract][Full Text] [Related]
3. Formation of colloidal suspension of hydrophobic compounds with an amphiphilic self-assembling peptide.
Fung SY; Yang H; Chen P
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):200-11. PubMed ID: 17234393
[TBL] [Abstract][Full Text] [Related]
4. Self-assembling peptide-based nanoparticles enhance cellular delivery of the hydrophobic anticancer drug ellipticine through caveolae-dependent endocytosis.
Bawa R; Fung SY; Shiozaki A; Yang H; Zheng G; Keshavjee S; Liu M
Nanomedicine; 2012 Jul; 8(5):647-54. PubMed ID: 21889478
[TBL] [Abstract][Full Text] [Related]
5. Release of hydrophobic anticancer drug from a newly designed self-assembling peptide.
Wu M; Ye Z; Liu Y; Liu B; Zhao X
Mol Biosyst; 2011 Jun; 7(6):2040-7. PubMed ID: 21491031
[TBL] [Abstract][Full Text] [Related]
6. Molecular binding of self-assembling peptide EAK16-II with anticancer agent EPT and its implication in cancer cell inhibition.
Lu S; Wang H; Sheng Y; Liu M; Chen P
J Control Release; 2012 May; 160(1):33-40. PubMed ID: 22465389
[TBL] [Abstract][Full Text] [Related]
7. Self/co-assembling peptide, EAR8-II, as a potential carrier for a hydrophobic anticancer drug pirarubicin (THP)--characterization and in-vitro delivery.
Sadatmousavi P; Chen P
Int J Mol Sci; 2013 Nov; 14(12):23315-29. PubMed ID: 24287908
[TBL] [Abstract][Full Text] [Related]
8. Effect of amino acid sequence and pH on nanofiber formation of self-assembling peptides EAK16-II and EAK16-IV.
Hong Y; Legge RL; Zhang S; Chen P
Biomacromolecules; 2003; 4(5):1433-42. PubMed ID: 12959616
[TBL] [Abstract][Full Text] [Related]
9. Arginine-rich ionic complementary peptides as potential drug carriers: Impact of peptide sequence on size, shape and cell specificity.
Wan Z; Lu S; Zhao D; Ding Y; Chen P
Nanomedicine; 2016 Aug; 12(6):1479-88. PubMed ID: 26949161
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of peptide mediated delivery of anticancer drug ellipticine.
Ma W; Lu S; Pan P; Sadatmousavi P; Yuan Y; Chen P
PLoS One; 2012; 7(8):e43684. PubMed ID: 22952737
[TBL] [Abstract][Full Text] [Related]
11. Preparation of pH-responsive polymer core-shell nanospheres for delivery of hydrophobic antineoplastic drug ellipticine.
Wang H; Yang L; Rempel GL
Macromol Biosci; 2014 Feb; 14(2):166-72. PubMed ID: 24106137
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells.
Martinkova E; Dontenwill M; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():60-6. PubMed ID: 20027146
[TBL] [Abstract][Full Text] [Related]
13. Ellipticine binds to a human telomere sequence: an additional mode of action as a putative anticancer agent?
Ghosh S; Kar A; Chowdhury S; Dasgupta D
Biochemistry; 2013 Jun; 52(24):4127-37. PubMed ID: 23697684
[TBL] [Abstract][Full Text] [Related]
14. Diethylene glycol functionalized self-assembling peptide nanofibers and their hydrophobic drug delivery potential.
Sadatmousavi P; Mamo T; Chen P
Acta Biomater; 2012 Sep; 8(9):3241-50. PubMed ID: 22641104
[TBL] [Abstract][Full Text] [Related]
15. Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent.
Liu J; Zeng F; Allen C
J Control Release; 2005 Mar; 103(2):481-97. PubMed ID: 15763628
[TBL] [Abstract][Full Text] [Related]
16. Self-assembling peptide as a potential carrier of hydrophobic compounds.
Keyes C; Duhamel J; Fung SY; Bezaire J; Chen P
J Am Chem Soc; 2004 Jun; 126(24):7522-32. PubMed ID: 15198599
[TBL] [Abstract][Full Text] [Related]
17. Modification of hydrophilic and hydrophobic surfaces using an ionic-complementary peptide.
Yang H; Fung SY; Pritzker M; Chen P
PLoS One; 2007 Dec; 2(12):e1325. PubMed ID: 18091996
[TBL] [Abstract][Full Text] [Related]
18. Ellipticine, its Derivatives: Re-evaluation of Clinical Suitability with the Aid of Drug Delivery Systems.
Dan VM; Varghese TS; Viswanathan G; Baby S
Curr Cancer Drug Targets; 2020; 20(1):33-46. PubMed ID: 31560288
[TBL] [Abstract][Full Text] [Related]
19. Surface-driven first-step events of nanoscale self-assembly for molecular peptide fibers: An experimental and theoretical study.
Forte G; Messina GML; Zamuner A; Dettin M; Grassi A; Marletta G
Colloids Surf B Biointerfaces; 2018 Aug; 168():148-155. PubMed ID: 29395383
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
Poljaková J; Eckschlager T; Hrabeta J; Hrebacková J; Smutný S; Frei E; Martínek V; Kizek R; Stiborová M
Biochem Pharmacol; 2009 May; 77(9):1466-79. PubMed ID: 19426684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
